Pulmonary Hypertension Biorepository and Registry

Launched by UNIVERSITY OF KANSAS MEDICAL CENTER · Mar 17, 2021

Keywords

ClinConnect Summary

The Pulmonary Hypertension Biorepository and Registry trial is focused on understanding various types of pulmonary hypertension, a condition that affects the blood vessels in the lungs and can lead to serious health issues. This study aims to collect information and biological samples from patients with pulmonary hypertension to help researchers learn more about the disease and improve treatment options.

To be eligible for this trial, participants need to be at least 18 years old and have a confirmed diagnosis of pulmonary hypertension, which is usually confirmed through a specific test called right heart catheterization. The study is open to anyone, regardless of gender, who is a patient at TUKHS or has agreed to take part in an approved study. If someone decides they do not want to participate or cannot provide consent, they will not be included. Participants can expect to contribute to important research that could lead to better understanding and management of pulmonary hypertension.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP)
• • 2. The participant has a diagnosis of pulmonary hypertension confirmed by right heart catheterization
• • 3. Patient is ≥ 18 years of age or older
• Exclusion Criteria:
• • 1. Participant declines to participate (living patients only)
• • 2. Participant is unable to provide informed consent (living patients only)